{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:42:21Z","timestamp":1787920941903,"version":"build-2784847793"},"reference-count":25,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,25]]},"DOI":"10.1182\/blood.2022015936","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T20:01:23Z","timestamp":1657310483000},"page":"922-927","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database"],"prefix":"10.1182","volume":"140","author":[{"given":"S\u00e9gol\u00e8ne","family":"Fuentes","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-2489","authenticated-orcid":false,"given":"Basile","family":"Chr\u00e9tien","sequence":"additional","affiliation":[{"name":"2Department of Pharmacology, CHU de Caen Normandie, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dolladille","sequence":"additional","affiliation":[{"name":"2Department of Pharmacology, CHU de Caen Normandie, Caen, France;"},{"name":"3Normandie University, UNICAEN, INSERM U1086 ANTICIPE, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Alexandre","sequence":"additional","affiliation":[{"name":"2Department of Pharmacology, CHU de Caen Normandie, Caen, France;"},{"name":"3Normandie University, UNICAEN, INSERM U1086 ANTICIPE, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00ebl","family":"Dumont","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"de Boysson","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"},{"name":"4Normandie University, UNICAEN, UR4650 PSIR, CHU de Caen Normandie, Caen, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ch\u00e8ze","sequence":"additional","affiliation":[{"name":"5Department of Hematology, CHU de Caen Normandie, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9nola","family":"Maign\u00e9","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"},{"name":"4Normandie University, UNICAEN, UR4650 PSIR, CHU de Caen Normandie, Caen, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-3233","authenticated-orcid":false,"given":"Samuel","family":"Deshayes","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Normandie University, Universit\u00e9 de Caen Normandie (UNICAEN), Centre Hospitalo-Universitaire (CHU) de Caen Normandie, Caen, France;"},{"name":"4Normandie University, UNICAEN, UR4650 PSIR, CHU de Caen Normandie, Caen, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2022082515223456500_B1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2007-1005047","article-title":"Drug-induced platelet destruction","volume":"8","author":"Hackett","year":"1982","journal-title":"Semin Thromb Hemost."},{"issue":"1","key":"2022082515223456500_B2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","article-title":"Drug-induced thrombocytopenia: pathogenesis, evaluation, and management","volume":"2009","author":"George","year":"2009","journal-title":"Am Soc Hematol Educ Program."},{"issue":"6","key":"2022082515223456500_B3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N Engl J Med."},{"issue":"12","key":"2022082515223456500_B4","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2010-03-276691","article-title":"Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods","volume":"116","author":"Reese","year":"2010","journal-title":"Blood."},{"issue":"6","key":"2022082515223456500_B5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09537104.2011.633179","article-title":"Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database","volume":"23","author":"Moulis","year":"2012","journal-title":"Platelets."},{"issue":"5","key":"2022082515223456500_B6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-011-1184-3","article-title":"Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study","volume":"68","author":"Garbe","year":"2012","journal-title":"Eur J Clin Pharmacol."},{"issue":"6","key":"2022082515223456500_B7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br J Haematol."},{"issue":"25","key":"2022082515223456500_B8","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/bloodadvances.2017010942","article-title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry","volume":"1","author":"Arnold","year":"2017","journal-title":"Blood Adv."},{"issue":"22","key":"2022082515223456500_B9","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"6","key":"2022082515223456500_B10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","article-title":"Uses of pharmacovigilance databases: an overview","volume":"75","author":"Bihan","year":"2020","journal-title":"Therapie."},{"key":"2022082515223456500_B11","article-title":"Screening for adverse reactions in EudraVigilance","author":"European Medicines Agency"},{"issue":"3","key":"2022082515223456500_B12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0039-1683416","article-title":"Epidemiology and clinical manifestations of immune thrombocytopenia","volume":"39","author":"Kohli","year":"2019","journal-title":"Hamostaseologie."},{"issue":"11 11_Part_1","key":"2022082515223456500_B13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med."},{"issue":"2-3","key":"2022082515223456500_B14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol Res."},{"issue":"19","key":"2022082515223456500_B15","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.vaccine.2011.06.009","article-title":"A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine."},{"issue":"3","key":"2022082515223456500_B16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.vaccine.2017.05.012","article-title":"Enhancing global vaccine pharmacovigilance: proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination","volume":"36","author":"Perez-Vilar","year":"2018","journal-title":"Vaccine."},{"issue":"5","key":"2022082515223456500_B17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee","year":"2021","journal-title":"Am J Hematol."},{"issue":"3","key":"2022082515223456500_B18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.17645","article-title":"Exacerbation of immune thrombocytopenia following COVID-19 vaccination","volume":"195","author":"Kuter","year":"2021","journal-title":"Br J Haematol."},{"key":"2022082515223456500_B19","article-title":"American Society of Haematology","author":"COVID-19 and ITP"},{"issue":"5","key":"2022082515223456500_B20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/bjh.17813","article-title":"Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia","volume":"195","author":"Crickx","year":"2021","journal-title":"Br J Haematol."},{"issue":"7","key":"2022082515223456500_B21","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne","year":"2020","journal-title":"J Clin Med."},{"issue":"9","key":"2022082515223456500_B22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-induced immune thrombocytopenia","volume":"356","author":"Von Drygalski","year":"2007","journal-title":"N Engl J Med."},{"key":"2022082515223456500_B23","doi-asserted-by":"crossref","first-page":"530478","DOI":"10.3389\/fonc.2020.530478","article-title":"Immune thrombocytopenia induced by immune checkpoint inhibitors in solid cancer: case report and literature review","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol."},{"issue":"11","key":"2022082515223456500_B24","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1007\/s00415-018-8822-y","article-title":"Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations","volume":"265","author":"Devonshire","year":"2018","journal-title":"J Neurol."},{"issue":"24","key":"2022082515223456500_B25","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1182\/blood-2011-08-371138","article-title":"A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis","volume":"118","author":"Cuker","year":"2011","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/8\/922\/1916633\/bloodbld2022015936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/8\/922\/1916633\/bloodbld2022015936.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T15:23:30Z","timestamp":1661441010000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/8\/922\/485825\/An-updated-list-of-drugs-suspected-to-be"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022015936","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]}}}